PureTech News

Press Releases
ALL >
Press Release - 2026-06-10
Other
Results of Annual General Meeting
Press Release - 2026-06-09
Seaport
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
Press Release - 2026-05-13
Celea Therapeutics – Deupirfenidone (LYT-100)
PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference
Publications
ALL >
Publications 2026-04-02
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial
Publications 2026-03-25
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans
Publications 2025-05-08
Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study

@PureTechH